| __timestamp | Amicus Therapeutics, Inc. | MorphoSys AG |
|---|---|---|
| Wednesday, January 1, 2014 | 20717000 | 9689000 |
| Thursday, January 1, 2015 | 47269000 | 10431000 |
| Friday, January 1, 2016 | 71151000 | 9618000 |
| Sunday, January 1, 2017 | 88671000 | 12348000 |
| Monday, January 1, 2018 | 127200000 | 28310241 |
| Tuesday, January 1, 2019 | 169861000 | 59336147 |
| Wednesday, January 1, 2020 | 156407000 | 159145941 |
| Friday, January 1, 2021 | 192710000 | 199800000 |
| Saturday, January 1, 2022 | 213041000 | 90225000 |
| Sunday, January 1, 2023 | 275270000 | 92538000 |
Cracking the code
In the ever-evolving pharmaceutical landscape, operational efficiency is paramount. Over the past decade, Amicus Therapeutics, Inc. has consistently outpaced MorphoSys AG in Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Amicus's SG&A expenses surged by over 1,200%, peaking in 2023. In contrast, MorphoSys AG's expenses grew by approximately 850% during the same period. Notably, in 2020 and 2021, MorphoSys AG briefly surpassed Amicus, reflecting strategic investments. However, by 2023, Amicus reclaimed its lead, spending nearly three times more than MorphoSys. This trend underscores Amicus's aggressive market strategies and expansion efforts. As both companies navigate the competitive biotech sector, their SG&A trajectories offer insights into their operational priorities and market positioning.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or MorphoSys AG
Intra-Cellular Therapies, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Insmed Incorporated and MorphoSys AG
Bio-Techne Corporation or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Grifols, S.A. and MorphoSys AG
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs MorphoSys AG Trends and Insights
Alkermes plc and MorphoSys AG: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing PTC Therapeutics, Inc. and Amicus Therapeutics, Inc.
Who Optimizes SG&A Costs Better? MorphoSys AG or Taro Pharmaceutical Industries Ltd.
Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Amicus Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Breaking Down SG&A Expenses: Amicus Therapeutics, Inc. vs MannKind Corporation